pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
ASD-006
Atherosclerosis
Asdera LLC
0
catalysts
Phase 1
ASD-141
Solid Tumor
Ascendo Biotechnology Inc
0
catalysts
ASENAPINE
ASENAPINE (ASENAPINE)
SIGMAPHARM LABS LLC
0
catalysts
pre_registration
ASN-006
Venous Thromboembolism
Auson Pharmaceuticals Inc
catalysts
← prev
page 59 of 271
next →
131
Pain
89
Neurology
1
0
Phase 1
ASP-001.1
sildenafil citrate
Erectile Dysfunction
cGMP-specific 3',5'-cyclic phosphodiesterase
Aspargo Laboratories Inc
0
catalysts
Phase 2
ASP-2957
X-Linked Myotubular Myopathy (XLMTM or MTM)
Astellas Pharma Inc
0
catalysts
Phase 2
ASP-7316
Juvenile Macular Degeneration (Stargardt Disease)
Astellas Pharma Inc
0
catalysts
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE (ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)
MICRO LABS
0
catalysts
Phase 1
AST-021p
Epithelial Ovarian Cancer
Aston Sci Inc
0
catalysts
Phase 1
AST-201
Ovarian Cancer
EpiThany Inc
0
catalysts
Preclinical
AT-001
Radiation Injury
Adipothera Inc
0
catalysts
Preclinical
AT-002
Bone Disorders
Adipothera Inc
0
catalysts
Phase 1
AT-0365
Breast Cancer
Axcynsis Therapeutics Pte Ltd
0
catalysts
Preclinical
AT-1082
Smoking Cessation
Astraea Therapeutics LLC
0
catalysts
Preclinical
AT-211
Adenocarcinoma Of The Gastroesophageal Junction
AbTis Co Ltd
0
catalysts
Phase 1
AT-278
insulin human
Type 2 Diabetes
Insulin receptor
Arecor Therapeutics Plc
0
catalysts
Phase 1
AT-7687
Obesity
Antag Therapeutics ApS
0
catalysts
Phase 1
ATA-100
Limb-Girdle Muscular Dystrophy
Atamyo Therapeutics SAS
0
catalysts
Phase 2
ATA-200
Limb-Girdle Muscular Dystrophy
Atamyo Therapeutics SAS
0
catalysts
Phase 1
ATA-2271
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
0
catalysts
ATAZANAVIR
ATAZANAVIR (ATAZANAVIR)
LAURUS
0
catalysts
Preclinical
ATB-352
Post-Operative Pain
Sun Pharmaceutical Industries Ltd
0
catalysts
Phase 1
ATCell
Traumatic Brain Injury
American CryoStem Corp
0
catalysts
ATENOLOL AND CHLORTHALIDONE
ATENOLOL AND CHLORTHALIDONE (ATENOLOL AND CHLORTHALIDONE)
UNICHEM
0
catalysts
Preclinical
ATG-012
Solid Tumor
Antengene Corp Ltd
0
catalysts
Phase 1
ATG-031
B-Cell Non-Hodgkin Lymphoma
Antengene Corp Ltd
0
catalysts
Phase 1
ATH-1020
Neurodegenerative Diseases
$LONA
LeonaBio, Inc.
0
catalysts
Phase 1
ATH-1105
Amyotrophic Lateral Sclerosis
$LONA
LeonaBio, Inc.
0
catalysts
Phase 1
ATH-399A
Parkinson's Disease
NurrOn Pharmaceuticals Inc
0
catalysts
Phase 2
ATH-434
Multiple System Atrophy (Multi-System Degeneration)
$ATHE
ALTERITY THERAPEUTICS LTD
0
catalysts
